Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Excited visitors for NASA's moon launch jockey for prime views - 2NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- 3The most effective method to Go Down Abundance through Ages with Disc Rates
- 4What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- 5ADHD drugs work, but not the way experts thought
- David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
- Genome study reveals milestone in history of cat domestication
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Everyday Seasonal Positions That Compensate Fairly in the US
- Doctors looking into hormone therapy as a way to ward off dementia in women
- 'Unreal' solar eclipse: Artemis 2 crew just saw one of the rarest sights in spaceflight history
- Taylor Frankie Paul's domestic violence case is fueling discussions about DARVO. Experts say terms like this shouldn't be used lightly.
